Pharmacological treatment of osteoporosis in the oldest old.

about

Pharmacological treatment of osteoporosis in the oldest old.

Item

http://www.wikidata.org/entity/Q39455613

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Pharmacological treatment of osteoporosis in the oldest old.

@en

Pharmacological treatment of osteoporosis in the oldest old.

@nl

type

Item

label

Pharmacological treatment of osteoporosis in the oldest old.

@en

Pharmacological treatment of osteoporosis in the oldest old.

@nl

prefLabel

Pharmacological treatment of osteoporosis in the oldest old.

@en

Pharmacological treatment of osteoporosis in the oldest old.

@nl

P1476

Pharmacological treatment of osteoporosis in the oldest old.

@en

P2093

A Vandenbroucke

http://www.w3.org/2001/XMLSchema#string

E Gielen

http://www.w3.org/2001/XMLSchema#string

F P Luyten

http://www.w3.org/2001/XMLSchema#string

J Flamaing

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline

The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know

Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis

Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis

Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis

Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe

Frailty in older adults: evidence for a phenotype

The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

P304

1065-1077

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.2147/CIA.S131023

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2017-07-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28740372

http://www.w3.org/2001/XMLSchema#string

P921

osteoporosis

P932

5505539

http://www.w3.org/2001/XMLSchema#string